Literature DB >> 6600103

Nonrandom sampling in human genetics: familial correlations.

C L Hanis1, R Chakraborty.   

Abstract

In the context of human genetics, sampling is often nonrandom in that pedigrees are frequently selected by virtue of their having at least one affected individual. For quantitative traits, it may be that the proband is selected because of a phenotypic value above some predetermined cut-point; this will also be true for diseases defined by a cut-point above which individuals are said to be affected (e.g. diabetes, hypertension, and obesity). Relatively little attention has been given to the implications of these forms of nonrandom sampling. In this paper, we show that the biases introduced by such sampling are sufficient to lead to erroneous model specification and biased parameter estimates in path analysis. Existing methodologies used to correct for such sampling (e.g., elimination of proband or regression techniques) also result in similar bias in estimation and model fitting. Thus, it is possible to make inferences which do not reflect underlying biology, but are artifacts of the sampling design. As a consequence, method-of-moment estimators are developed for means, variances, and correlations under such sampling. Simulation results are used to demonstrate the superiority of this method over alternate strategies.

Entities:  

Mesh:

Year:  1984        PMID: 6600103     DOI: 10.1093/imammb/1.2.193

Source DB:  PubMed          Journal:  IMA J Math Appl Med Biol        ISSN: 0265-0746


  2 in total

1.  Correcting for single ascertainment by truncation for a quantitative trait.

Authors:  M R Young; M Boehnke; P P Moll
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

2.  G(2) chromosomal radiosensitivity in Danish survivors of childhood and adolescent cancer and their offspring.

Authors:  G B Curwen; J F Winther; E J Tawn; V Smart; C A Whitehouse; G S Rees; J H Olsen; P Guldberg; C Rechnitzer; H Schrøder; P E Bryant; X Sheng; H S Lee; R Chakraborty; J D Boice
Journal:  Br J Cancer       Date:  2005-10-31       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.